MND: An Israeli work published in 2006 in the Journal of Leukocyte biology paved way for subsequent studies of extracts of the hydrangea bush as a treatment for auto immune diseases such as MS:

Quoting: “… Halofuginone inhibits activated peripheral blood T cell functions and proinflammatory cytokine production…It also inhibited DTH response in vivo, making it an attractive immunomodulator and anti-inflammatory agent….”     Click Here for link to article’s entry in PubMed

Hydrangea: Beauty and Healing?

MND:  A later study published in the Journal “Nature”   further concludes: “…halofuginone is a specific inhibitor of TH17 cell differentiation . …..[TH17] known to have a role in the induction of autoimmune diseases…..].

MND:Quoting an entry in :

“…halofuginone promises to be a gentler and more effective drug. It is found to suppress the production of a particular immune system cell, the Th17,..”

MND: Next?

2 Comments for this entry

Leave a Reply

Your email address will not be published. Required fields are marked *

Current month ye@r day *

© 2013-2019 Medical News Digest All Rights Reserved